Abstract:Acne vulgaris is a cutaneous chronic inflammatory disorder with complex pathogenesis. Four factors play vital roles in acne pathophysiology: hyperseborrhea and dysseborrhea, altered keratinization of the pilosebaceous duct, Cutibacterium acnes (C. acnes) and inflammation. The main hormones responsible for the development of acne vulgaris include androgens, insulin and insulin-like growth factor-1. Other factors involved in this process are corticotropin-releasing hormone, α-melanocyte-stimulating hormone and substance P. Wnt/β-catenin signaling pathway, phosphoinositide 3-kinase (PI3K)/Akt pathway, mitogen-activated protein kinase pathway, adenosine 5′-monophosphate-activated protein kinase pathway and nuclear factor kappa B pathway participate in the modulation of sebocyte, keratinocyte and inflammatory cell (e.g. lymphocytes, monocytes, macrophages, neutrophils) activity. Among all the triggers and pathways mentioned above, IGF-1-induced PI3K/Akt/Forkhead box protein O1/mammalian target of rapamycin (mTOR) C1 pathway is the most important signaling responsible for acne pathogenesis. Commonly used anti-acne agents include retinoids, benzoyl peroxide, antibiotics and hormonal agents (e.g. spironolactone, combination oral contraceptive and flutamide). New approaches including peroxisome proliferator-activated receptor γ modifier, melanocortin receptor antagonists, epigallocatechin-3-gallate, metformin, olumacostat glasaretil, stearoyl-CoA desaturase inhibitor omiganan pentahydrochloride, KDPT, afamelanotide, apremilast and biologics have been developed as promising treatments for acne vulgaris. Although these anti-acne agents have various pharmacological effects against the diverse pathogenesis of acne, all of them have a synergistic mode of action, the attenuation of Akt/mTORC1 signaling and enhancement of p53 signal transduction. In addition to drug therapy, diet with no hyperglycemic carbohydrates, no milk and dairy products is also beneficial for treatment of acne.

Role of the Insulin-Like Growth Factor 1 Receptor Signaling Pathway in the Pathogenesis of Related Skin Diseases

Insulin-like Growth Factors and Dermatosis

Novel Aspects of Insulin-like Growth Factor 1/insulin Network in Chronic Inflammatory Airway Disease

Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases

The Roles of Insulin-Like Growth Factor Binding Protein Family in Development and Diseases

The PI3K/Akt Pathway: Emerging Roles in Skin Homeostasis and a Group of Non-Malignant Skin Disorders

Advances in Targeting Insulin-Like Growth Factor Signaling Pathway in Cancer Treatment.

[Advancements in Expression of Vascular Endothelial Growth Factor Receptors in Skin Diseases].

Relationship Between Acne and Insulin Resistance

Characteristics of Insulin-Like Growth Factor-ⅰ Receptor Expression in Hypertrophic Scars and Its Biological Significance

Progress of IGFs and Its Signaling Pathway

[Signaling Pathways in the Pathogenesis of Acne Vulgaris].

Crosstalk Between Igf-1r and Other Tumor Promoting Pathways

IGF signaling pathway in bone and cartilage development, homeostasis, and disease

From pathogenesis of acne vulgaris to anti-acne agents

Relationship Between IGF and Intestinal Fibrosis and Its Regulation by Acupuncture

Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors in cancer therapy: advances and perspectives.

[Transforming Growth Factor-Beta and Its Receptors in Scleroderma].

Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins: roles in skeletal muscle growth and differentiation.

Type I Insulin-Like Growth Factor Receptor and Tumor

Research Progress of Insulin-Like Growth Factor Binding Protein IGFBP-3